FREE Webinar: Streamlining Biomarker Discover

11th April, 2.00pm BST

Introducing our NEW ESR1 Mutations Kit!

Highly sensitive detection of 11 ESR1 mutations

APIS Breast Cancer Subtyping Kit

Diagnostic kit for detecting mRNA expression of biomarkers

APIS Target Triage (ATTTM)

Effectively validate drug or biomarker targets

Introducing APIS Assay Technologies

APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility.

APIS has deep expertise and capabilities in IVD development of molecular & immune-assays for ultimate product realisation as diagnostic tests.

Please contact info@apisassay.com to discuss your diagnostic requirements further.

Our Mission:

To leverage our expertise in the design, development, and supply of diagnostic assays, therapeutic solutions, and bioinformatics. To enable faster, accurate prediction and prevention of disease, driven by the ambition to improve human health.

We are committed at APIS to realise the clinical potential of systems biology and medicine in the diagnosis and personalisation of treatment. We seek to develop biomarkers that deliver significant improvements in the prediction and prevention of disease.

Benefiting from our proven track record in delivering Molecular In Vitro Diagnostic products, into highly regulated markets (e.g. through FDA and CE-Marking), APIS Assay Technologies brings the benefits of novel, transformational molecular diagnostics and integrated Bioinformatics to Greater Manchester and further beyond into the global healthcare market.

Breast Cancer Product Portfolio

Innovative Solutions for Breast Cancer; Advanced Assays with Precise Results.

  • The APIS Breast Cancer Subtyping Kit is a highly reproducible, RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers

  • The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The kit has a wide target coverage of 11 different ESR1 receptor gene mutations.

Contract IVD Development

The Contract Development activity operates as a distinct commercial service line, with focus on the tailored development of novel molecular diagnostic tests on medical diagnostic platforms.

Bioinformatics and Software Development

Bioinformatics is an interdisciplinary field of science that combines biology, computer science, information engineering, mathematics, and statistics.

The primary goal of bioinformatics is the in-silico analysis and interpretation of higher-order biological data by applying existing, and/or developing novel mathematical methods and software tools.

Clickmer Systems

Synthetic antibody analogues known as Clickmers are chemically modified ssDNA oligonucleotides that, based on their sequence and modifications, form three-dimensional structures that adaptively bind to their target molecules with high affinity and specificity.